In addition to rediscovering previously known recurrent kinase fusions, we identified new fusion partners for many genes (for example, TPM1–ALK in bladder cancer, TBL1XR1–RET in thyroid cancer, and so on). Here, RET is linked to thyroid gland carcinoma.